Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Basic Science Investigation

  • Repeatability of <sup>68</sup>Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume
    You have access
    Repeatability of 68Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume
    Robert Seifert, Patrick Sandach, David Kersting, Wolfgang P. Fendler, Boris Hadaschik, Ken Herrmann, John J. Sunderland and Janet H. Pollard
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 746-753; DOI: https://doi.org/10.2967/jnumed.121.262528
  • First In Vivo and Phantom Imaging of Cyclotron-Produced <sup>133</sup>La as a Theranostic Radionuclide for <sup>225</sup>Ac and <sup>135</sup>La
    Open Access
    First In Vivo and Phantom Imaging of Cyclotron-Produced 133La as a Theranostic Radionuclide for 225Ac and 135La
    Bryce J.B. Nelson, Simon Ferguson, Melinda Wuest, John Wilson, M. John M. Duke, Susan Richter, Hans Soenke-Jans, Jan D. Andersson, Freimut Juengling and Frank Wuest
    Journal of Nuclear Medicine April 1, 2022, 63 (4) 584-590; DOI: https://doi.org/10.2967/jnumed.121.262459
  • Influence of Fc Modifications and IgG Subclass on Biodistribution of Humanized Antibodies Targeting L1CAM
    You have access
    Influence of Fc Modifications and IgG Subclass on Biodistribution of Humanized Antibodies Targeting L1CAM
    Sai Kiran Sharma, Maya Suzuki, Hong Xu, Joshua A. Korsen, Zachary Samuels, Hongfen Guo, Brandon Nemieboka, Alessandra Piersigilli, Kimberly J. Edwards, Nai-Kong V. Cheung and Jason S. Lewis
    Journal of Nuclear Medicine April 1, 2022, 63 (4) 629-636; DOI: https://doi.org/10.2967/jnumed.121.262383
  • You have access
    RADAR Guide: Standard Methods for Calculating Radiation Doses for Radiopharmaceuticals, Part 2—Data Analysis and Dosimetry
    Michael G. Stabin, Richard E. Wendt and Glenn D. Flux
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 485-492; DOI: https://doi.org/10.2967/jnumed.121.262034
  • A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor–Positive Prostate Cancer
    You have access
    A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor–Positive Prostate Cancer
    Ivica J. Bratanovic, Chengcheng Zhang, Zhengxing Zhang, Hsiou‐Ting Kuo, Nadine Colpo, Jutta Zeisler, Helen Merkens, Carlos Uribe, Kuo‐Shyan Lin and François Bénard
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 424-430; DOI: https://doi.org/10.2967/jnumed.120.257758
  • Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard
    You have access
    Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard
    George A. Prenosil, Hasan Sari, Markus Fürstner, Ali Afshar-Oromieh, Kuangyu Shi, Axel Rominger and Michael Hentschel
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 476-484; DOI: https://doi.org/10.2967/jnumed.121.261972
  • Glitter in the Darkness? Nonfibrillar β-Amyloid Plaque Components Significantly Impact the β-Amyloid PET Signal in Mouse Models of Alzheimer Disease
    Open Access
    Glitter in the Darkness? Nonfibrillar β-Amyloid Plaque Components Significantly Impact the β-Amyloid PET Signal in Mouse Models of Alzheimer Disease
    Gloria Biechele, Laura Sebastian Monasor, Karin Wind, Tanja Blume, Samira Parhizkar, Thomas Arzberger, Christian Sacher, Leonie Beyer, Florian Eckenweber, Franz-Josef Gildehaus, Barbara von Ungern-Sternberg, Michael Willem, Peter Bartenstein, Paul Cumming, Axel Rominger, Jochen Herms, Stefan F. Lichtenthaler, Christian Haass, Sabina Tahirovic and Matthias Brendel
    Journal of Nuclear Medicine January 1, 2022, 63 (1) 117-124; DOI: https://doi.org/10.2967/jnumed.120.261858
  • Patient Size-Dependent Dosimetry Methodology Applied to <sup>18</sup>F-FDG Using New ICRP Mesh Phantoms
    You have access
    Patient Size-Dependent Dosimetry Methodology Applied to 18F-FDG Using New ICRP Mesh Phantoms
    Lukas M. Carter, Chansoo Choi, Simone Krebs, Bradley J. Beattie, Chan Hyeong Kim, Heiko Schoder, Wesley E. Bolch and Adam L. Kesner
    Journal of Nuclear Medicine December 1, 2021, 62 (12) 1805-1814; DOI: https://doi.org/10.2967/jnumed.120.256719
  • Cyclic <sup>68</sup>Ga-Labeled Peptides for Specific Detection of Human Angiotensin-Converting Enzyme 2
    Open Access
    Cyclic 68Ga-Labeled Peptides for Specific Detection of Human Angiotensin-Converting Enzyme 2
    Matthew F.L. Parker, Joseph Blecha, Oren Rosenberg, Michael Ohliger, Robert R. Flavell and David M. Wilson
    Journal of Nuclear Medicine November 1, 2021, 62 (11) 1631-1637; DOI: https://doi.org/10.2967/jnumed.120.261768
  • Site-Specific and Residualizing Linker for <sup>18</sup>F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment
    You have access
    Site-Specific and Residualizing Linker for 18F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment
    Zhengyuan Zhou, Rebecca Meshaw, Michael R. Zalutsky and Ganesan Vaidyanathan
    Journal of Nuclear Medicine November 1, 2021, 62 (11) 1624-1630; DOI: https://doi.org/10.2967/jnumed.120.261446

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 31
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire